Advancing Vaccines in the Genomics Era (T1)

Organized by Bali Pulendran of Emory University, Chris Wilson of Bill & Melinda Gates Foundation and Rino Rappuoli of Novartis Vaccines & Diagnostics, the conference will:
• Convene with a keynote address by Rino Rappuoli of Novartis Vaccines & Diagnostics on
+ show speakers and program
Keynote Address
Rino Rappuoli, Novartis Vaccines & Diagnostics, Italy
Reverse Vaccinology

Daniel Kastner, National Institutes of Health, USA
Understanding Human Immunity from Experiments of Nature

Thomas Richard Hawn, University of Washington, USA
Genetic Dissection of Innate Immunity during BCG Vaccination

Mary Carrington, Frederick National Laboratory for Cancer Research, USA
Immunogenetics of Spontaneous Control of HIV

Rafi Ahmed, Emory University School of Medicine, USA
Vaccination and Immune Memory

Rafick P. Sékaly, Vaccine & Gene Therapy Institute, USA
Gender and Ethnic Differences in the Response to Vaccines

J. Christopher Love, Massachusetts Institute of Technology, USA
Microtools for Probing T Cell Responses

Bali Pulendran, Emory University, USA
Systems Vaccinology

Alan Aderem, Seattle BioMed, USA
Systems Biological Approaches in Vaccine Development

Mark M. Davis, Stanford University, USA
A Systems Approach to Vaccination

Danilo R. Casimiro†, Merck Research Laboratories, USA
Using Transcriptional Profiling to Determine Signatures of Vaccine Immunoigenicity and Safety

Scott D. Boyd, Stanford University, USA
Deep Sequencing of the Antibody Repertoire during Vaccination

Antonio Lanzavecchia, Institute for Research in Biomedicine, Switzerland
Dissecting the Human B Cell Response to Pathogens

Hana Golding, Center for Biologics Evaluation & Research, U.S. Food and Drug Administration, USA
Expanding the Antibody Repertoire with Adjuvants

Peter D. Kwong, NIAID, National Institutes of Health, USA
Structural Vaccinology

Ian A. Wilson, The Scripps Research Institute, USA
Structural Insights into HIV and Influenza Antigen Design

Rhea N. Coler, Infectious Disease Research Institute, USA
Reverse Vaccinology for TB Antigen Discovery

Scott Presnell, Benaroya Research Institute at Virginia Mason, USA
Modular Approaches to Transcriptional Analyses of Vaccine Immunity

Mauro Martins Teixeira, Universidade Federal de Minas Gerais, Brazil
Mechanisms of Resistance and Disease in Dengue

Ricardo T. Gazzineli, CPQRR-Fiocruz, Brazil
Exploring Plasticity of Trypanosoma cruzi Genome in the Development of a Live Attenuated Vaccine Vector

Adrian V. S. Hill, University of Oxford, UK
Can Genes Help Design New Vaccines?

Jorg J. Goronzy, Stanford University School of Medicine, USA
Dissecting the T Cell Response in the Elderly

Bonnie B. Blomberg, University of Miami School of Medicine, USA
Biomarkers of Vaccine Efficacy in the Elderly

Ofer Levy, Children's Hospital Boston, USA
Microphysiologic Modeling of Immune Responses to Inform Age-Specific Vaccine Development

Andrew J. Pollard, University of Oxford, UK
Transcriptional Signatures of Adjuvanted Influenza Vaccines in Children

Lynda G. Tussey, VaxInnate Corporation, USA
Modifying the Agonist Properties of Flagellin to Improve Vaccine Performance

Ennio De Gregorio, Novartis Vaccines and Diagnostics, Italy
Genomic Approaches to Adjuvant Discovery

Robert L. Coffman, Dynavax Technologies, USA
Advancing TLR9 Ligands as Vaccine Adjuvants in Humans

31 Oct - 4 Nov 2013
Rio de Janeiro
meeting website